Atopic Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-01-2025
- Paid Up Capital ₹ 0.10 M
as on 02-01-2025
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.40 M
as on 02-01-2025
- Satisfied Charges ₹ 1.50 Cr
as on 02-01-2025
- Revenue -18.13%
(FY 2021)
- Profit 147.56%
(FY 2021)
- Ebitda 93.51%
(FY 2021)
- Net Worth 1.28%
(FY 2021)
- Total Assets -2.62%
(FY 2021)
About Atopic Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.40 M. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhupendra Patel, Rakeshbhai Patel, and Kaushal Patel serve as directors at the Company.
- CIN/LLPIN
U51397GJ2004PTC043878
- Company No.
043878
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Atopic Laboratories Private Limited offer?
Atopic Laboratories Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Hair Care Products, Common Disease Medicines, Antiseptic Mouthwashes, Anti-Itch Skin Cream, Pharmaceutical Tablets, Antifungal Injection, Tablet & Syrup, Itraconazole Capsule and Tablet, Pharmaceutical Medicine, Pharmaceutical Products.
Who are the key members and board of directors at Atopic Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupendra Patel  | Director | 29-Mar-2004 | Current |
| Rakeshbhai Patel | Director | 29-Mar-2004 | Current |
| Kaushal Patel | Director | 29-Mar-2004 | Current |
Financial Performance of Atopic Laboratories.
Atopic Laboratories Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 18.13% decrease. The company also saw a substantial improvement in profitability, with a 147.56% increase in profit. The company's net worth moved up by a moderate rise of 1.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atopic Laboratories?
In 2021, Atopic Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Atopic Tours And Travels LlpActive 3 years 8 monthsRakeshbhai Patel and Kaushal Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 28 Mar 2007 | ₹0.40 M | Open |
State Bank Of India Creation Date: 28 Feb 2007 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Atopic Laboratories?
Unlock and access historical data on people associated with Atopic Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atopic Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atopic Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
